Pre-clinical experimentation and clinical research
Pre-clinical experimentation and clinical research
Contact
Arronax Nantes > Pre-clinical experimentation and clinical research > Our publications > Talk > 2021

Preclinical experimentation and clinical research

  • Prédiction de survie à partir des images TEP dans le contexte du myélome multiple.
    Morvan L.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Recalage d’images TEP pour le suivi du cancer du sein métastatique.
    Fourcade C.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Local-mean preserving post-processing step for non-negativity enforcement in PET imaging: application to 90Y-PET.
    Millardet M.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Nouveaux biomarqueurs en imagerie du carcinome hépatocellulaire.
    David A.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • Développement de l’alphathérapie dans le traitement des tumeurs neuroendocrines différenciées.
    Lugat A.
    Journée scientifique TransForMed4Students, Nantes (Loire Atlantique), France, July 6 2021

  • 64Cu-ATSM as a therapeutic agent in solid tumor? preliminary results of a whole body human dosimetry study OP-0360.
    Varmenot N, Colombié M, Rousseau C, Haddad F, Ferrer L
    EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021

  • Preclinical study of Targeted Alpha Therapy using 211At-labeled phenylalaline derivative in a syngeneic Multiple Myeloma model OP-0106.
    Gaschet J, Echeynne R, Chouin N, Gazzola S, Guérard F, Gouard S, Marionnaud-Lambot S, Maubert AL, Alliot C, Hofgaard PO, Bogen B, Yan E, Haddad F, Kraeber-Bodéré F, Wheatcroft M, Gestin JF, Chérel M
    EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021

  • Preliminary evaluation of 64Cu-ATSM as a tracer of predictive assessment of neoadjuvant treatment response in locally advanced rectal cancer OP-0062.
    Colombié M, Ferrer L , Lacombe M, Fleury V, le Thiec M, Morel A, Maugerat B, Rusu D, Varmenot N, Tremolieres P, Allam N, Rio E, Guimas V, Masson I, Senellart H, Hiret S, Salaun PY, Campion L, Vidal A, Haddad F, Rauscher A, Kraeber-Bodéré F, Bourgeois M, Rousseau C
    EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021

  • In vivo theranostic evaluation of a 64Cu-radiolabelled antibody in a murine model of multiple myeloma
    Métivier C, Remaud-Le Saëc P, Marionneau-Lambot S, Davodeau F, Chauvet C, Saï-Maurel C, Hofgaard PO, Bogen B, Tripier R, Haddad F, Gaschet J, Chérel M, Chouin N, Faivre-Chauvet A, Rbah-Vidal L
    14th Workshop Adaptation of the tumour and its ecosystem to radiotherapies, Le Bono, France, September 22-25 2021

  • Interest of whole-body immuno-SPECT-CT for canine diffuse large B-cell lymphoma (DLBCL) staging before radioimmunotherapy (RIT) using an anti-CD22 monoclonal antibody
    Etienne F, Nguyen F, Becavin S, Bodet-Milin C, Bourgeois M, Vidal A, Abadie J, Bouhsina N, Davodeau F, Ibisch C, Chouin N
    European Society of Veterinary Oncology (ESVONC) Conference, virtual edition, May 28-29 2021